What is the market cap difference between MRK and PFE?

MRK has a market cap of $275.1B and PFE has a market cap of $144.4B. MRK has a 1.9x larger market capitalization than PFE

MRK vs PFE Stock Comparison

Compare Merck & Company, Inc. (MRK) and Pfizer, Inc. (PFE) side by side. View price, valuation, dividends, and financial metrics.

Merck & Company, Inc.

$111.38-1.79%

Healthcare / Drug Manufacturers - General · $275.1B market cap

Pfizer, Inc.

$25.33-1.63%

Healthcare / Drug Manufacturers - General · $144.4B market cap

Both MRK and PFE operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.

MRK has a 1.9x larger market capitalization than PFE.

PFE trades at a lower P/E ratio (19.3x) compared to MRK (31.4x), suggesting PFE may be more attractively valued relative to its earnings.

PFE offers a higher dividend yield (6.79%) vs MRK (3.05%), making it more attractive for income investors.

Looking at profitability, MRK has a profit margin of 13.6% while PFE's is 11.8%. MRK converts more of its revenue into profit.

In terms of growth, MRK has revenue growth of 4.9% versus 5.4% for PFE. PFE is growing its top line faster.

Which is a better investment, MRK or PFE?: Both stocks have different strengths. Merck & Company, Inc. (MRK) trades at $111.38 with a $275.1B market cap, while Pfizer, Inc. (PFE) trades at $25.33 with a $144.4B market cap. PFE trades at a lower P/E ratio (19.3x) compared to MRK (31.4x), suggesting PFE may be more attractively valued relative to its earnings. The better choice depends on your investment goals, time horizon, and risk tolerance.
Are MRK and PFE in the same sector?: Both MRK and PFE operate in the Healthcare sector within the Drug Manufacturers - General industry, making them direct competitors.
Do MRK and PFE pay dividends?: PFE offers a higher dividend yield (6.79%) vs MRK (3.05%), making it more attractive for income investors.